1.Clinical Research Guidelines for the Treatment of Stable Angina with New Uyghur Medicine (Draft)
Aibai SILAFU ; Maimaiti MAINISHA ; Pingshan WANG ; Lei ZHANG ; Gongshu LI ; Binglin LIU ; Jinfeng LI ; Jianyuan TANG ; Zhijian LI ; Abuduaini ABUDUJILILI
Chinese Journal of Information on Traditional Chinese Medicine 2015;(2):133-136
Uyghur medicine has not yet had the clinical research guidelines consistent with Uyghur medicine theory for its new medicine. In this research, retrospective multi-center study on medical records of Uyghur medicine diagnosis and treatment program of stable angina was conducted. Data about demography, diagnostics, therapeutics, efficacy evaluation, and nursing were collated and analyzed. Uyghur medicine syndrome diagnosis indicators and their contribution to stable angina were identified, and Uyghur medicine syndrome differentiation criteria were established. Uyghur medicine established its primary and secondary disease syndrome and its symptoms quantization table entries for the syndrome elements of Uyghur medicine syndrome differentiation criteria. Then combined with symptoms of angina and ECG changes, nitroglycerin stop and decrement rate, evaluation criteria for the efficacy of disease symptom combination were established. On this basis, in accordance with the technical requirements of the national new medicine evaluation, the study developed clinical research guidelines for the treatment of stable angina with new Uyghur medicine.
2.Clinical Research Guidelines for the Treatment of Eczema with New Uyghur Medicine ;(Draft)
Aibai SILAFU ; Maimaiti MAINISHA ; Wufuer TUERXUN ; Pingshan WANG ; Gongshu LI ; Binglin LIU ; Xiaojing PEI ; Jianyuan TANG ; Zhijian LI ; Abuduaini ABUDUJILILI
Chinese Journal of Information on Traditional Chinese Medicine 2015;(5):132-136
Retrospective multi-center study on medical records of Uyghur medicine diagnosis and treatment program of eczema was done. Demography, diagnostics, therapeutics, efficacy evaluation and nursing data and other information were collated and analyzed. With analysis and summary of the primary and the secondary symptoms, eczema was divided into four types:blood corruption type (Ofunetlengen Kan Tiplik), blue colored yellow bile type (Zenggereng Sapra Tiplik), abnormal black bile type (Hayri Tabii Savda Hilitlik), and salty phlegm type (Shor Belgem Hilitlik). Uyghur Medicine syndrome differentiation and efficacy evaluation criteria were established. Skin itching, lesion shape, and lesion area integral of patients were scored before and after the treatment, respectively. According to the improvement in symptoms of Uyghur medicine syndrome and life quality of patients, and the internal environment change, evaluation criteria for the efficacy of disease symptom combination were established. On this basis, in accordance with the technical requirements of the national new medicine assessment technology, the study developed clinical research guidelines for the treatment of eczema with new Uyghur medicine.
3.Guideline of Clinical Research of New Drugs of Traditional Uygur Medicine for Treatment of Psoriasis Vulgaris (Draft)
Aibai SILAFU ; Maimaiti MAINISHA ; Wufuer TURSUN ; Pingshan WANG ; Gongshu LI ; Binglin LIU ; Xiaojing PEI ; Jianyuan TANG ; Zhijian LI ; Abuduaini ABUDUJILILI
Chinese Journal of Information on Traditional Chinese Medicine 2015;(1):133-136
The multi-central clinical records retrospective survey for psoriasis vulgaris was carried out by collecting related information such as demographic, diagnostics, therapeutics, efficacy evaluation, nursing data, and so on. The Uygur medical differentiation classification standard about psoriasis vulgaris was established and it was divided into four types:abnormal Khan Hilit type, abnormal Sapra Hilit type, abnormal saltness Balgham Hilit type, and abnormal Sawda Hilit type, according to main symptom and secondary symptom feature. The disease efficacy evaluation standard was established based on score of surface area and severity of skin injury combining with the changes of main symptom and secondary symptoms. On the basis, guidelines for clinical research of new drugs of Uygur medicine used in the treatment of psoriasis vulgaris were formulated in accordance with the technical requirements and procedure of national center for drug evaluation.
4.Clinical Research Guidelines for Treatment of Common Cold with New Uyghur Medicine (Draft)
Abudukelimu ABUDUWAILI ; Aibai SILAFU ; Pingshan WANG ; Maitinuer YUSUFU ; Wusiman MUHAMAITI ; Maimaiti MAINISHA ; Aximu TUERHONG ; Hong ZHANG ; Liansheng BAI ; Jinfeng LI ; Zhijian LI ; Abuduaini ABUDUJILILI ; Gongshu LI ; Binglin LIU ; Xiaojing PEI ; Bei ZHOU
Chinese Journal of Information on Traditional Chinese Medicine 2017;24(5):1-4
In this study, retrospective multi-center study on medical records of Uyghur Medicine diagnosis and treatment program of common cold was done and demographic, diagnostic, therapeutic, efficacy evaluation and nursing data and other information were collected, sorted out and analyzed to determine the diagnostic cretiria of Uygur Medicine syndrome factors. Syndrome differentiation standard with the syndrome factors of the enrties of main syndromes and sub-syndromes and symptomatic diagnosis chart was established. Combined with the symptoms of common cold, the efficacy evaluation standards were established. On this basis, in accordance with the technical requirements of the national new medicine review, the study developed clinical research guidelines for the treatment of common cold with new Uyghur Medicine (draft).
5.Clinical Research Guidelines for Treatment of Hyperlipidemia with New Uyghur Medicine (Draft)
Abudukelimu ABUDUWAILI ; Aibai SILAFU ; Pingshan WANG ; Wufuer ASIYA ; Maitinuer YUSUFU ; Wusiman MUHAMAITI ; Maimaiti MAINISHA ; Aximu TUERHONG ; Hong ZHANG ; Liansheng BAI ; Jinfeng LI ; Zhijian LI ; Abuduaini ABUDUJILILI ; Gongshu LI ; Binglin LIU ; Xiaojing PEI ; Bei ZHOU
Chinese Journal of Information on Traditional Chinese Medicine 2017;24(6):1-5
Based on medical ethics, retrospective multi-center study on medical records of Uyghur Medicine diagnosis and treatment program of hyperlipidemia was done and demographic, diagnostic, therapeutic, efficacy evaluation, nursing data and other information were collated. The main and secondary disease manifestations of hyperlipidemia were analyzed inductively and hyperlipidemia were divided into 4 types in Uyghur Medicine field, which were surplus and sticky Kan type, Chuchumal Balgham type, Gaisiman Balgham type, and Koygan Savda type. Therefore, Uighur Medicine syndrome type standards of hyperlipidemia were established. Treatment efficacy was evaluated with the combination of laboratory observation parameters and main and secondary disease manifestations. On this basis, in accordance with the technical requirements of the national medicine review, this study developed clinical research guidelines for the treatment of hyperlipidemia with new Uyghur Medicine (draft).